Future perspectives of circulating tumor DNA in colorectal cancer.


Tumor biopsy is currently the gold standard for diagnosis and in determining cell signaling pathways involved in the development of treatment resistance. However, there are major challenges with this technique, including the need for serial sampling to monitor treatment resistance, which is invasive and also has the potential for selection bias due to intra… (More)
DOI: 10.1177/1010428317705749


Cite this paper

@article{Nadal2017FuturePO, title={Future perspectives of circulating tumor DNA in colorectal cancer.}, author={Cristina Nadal and Thomas L. Winder and A. Gerger and David Tougeron}, journal={Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine}, year={2017}, volume={39 5}, pages={1010428317705749} }